← FDA Drug Approvals (Drugs@FDA)
POTASSIUM PHOSPHATES
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AM REGENT · Approved 2023-10-02
Drug application
- FDA Application #
ANDA216274- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- POTASSIUM PHOSPHATES
- Generic name
- POTASSIUM PHOSPHATES
- Active ingredients
- POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- AM REGENT
- Manufacturer
- American Regent, Inc.
- First approval
- 2023-10-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown